Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
product
Inquiry Now

Tofacitinib Tablets

  • Product/Generic Name: Tofacitinib Tablets
  • Trade / Brand Name: Xeljanz
  • Available strength: 5 mg & 11 mg
  • Dosage form: Tablets (film – coated)
  • Therapeutic Category: JAK Inhibitor / Antirheumatic / Immunomodulator
  • Configuration: 6 x 10 / 10 x 10 Blisters (or as per buyer advice)
  • Production Capacity: 10 million tablets/month
Inquiry The Product
Send Inquiry

Lifechem Healthcare Private Limited is a leading pharmaceutical manufacturer and exporter based in Surat, India, dedicated to delivering high-quality autoimmune therapies globally. We specialize in the production and supply of Tofacitinib Tablets 11mg & 5mg, a premium Janus kinase (JAK) inhibitor used to manage Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative Colitis. Formulated in our state-of-the-art WHO-GMP certified facilities, our products meet stringent international regulatory standards for efficacy and safety.

As a trusted pharmaceutical exporter in India, we prioritize quality assurance and supply chain reliability for our B2B partners, hospital procurement teams, and global distributors.

  • WHO-GMP Certified: Manufactured in facilities that strictly adhere to Good Manufacturing Practices.

  • Regulatory Support: We provide complete documentation including COA, MOA, and Stability Data to assist with registration in your country.

  • Flexible Packaging: Available in standard blister packs (6×10, 10×10) or customized bulk packaging for export markets.

  • Global Reach: Currently exporting to over 40 countries with a robust logistics network ensuring timely delivery.

Here is a professional and pharmaceutical-grade product description for your website. It is structured to appeal to B2B buyers, distributors, and healthcare professionals.

Available Strengths

  • 5 mg (Immediate Release)

  • 11 mg (Extended Release)

Description

Tofacitinib is a potent, oral Janus kinase (JAK) inhibitor. It functions by inhibiting the JAK-STAT signaling pathway, which plays a pivotal role in the immune response and inflammation processes. By interfering with these pathways, Tofacitinib effectively modulates the immune system to reduce inflammation and associated symptoms in autoimmune conditions.

This product is formulated using high-grade Active Pharmaceutical Ingredients (API) and manufactured under strict quality control standards to ensure efficacy, stability, and bioavailability.

Indications

Tofacitinib is clinically indicated for the management of the following conditions:

  • Rheumatoid Arthritis (RA): For the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate.

  • Psoriatic Arthritis (PsA): For the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).

  • Ulcerative Colitis (UC): For the treatment of adult patients with moderately to severely active ulcerative colitis.

  • Juvenile Idiopathic Arthritis (JIA): (Depending on local regulatory approval) For the treatment of active polyarticular course juvenile idiopathic arthritis.

Packaging

We offer flexible packaging solutions tailored to market requirements and client preferences:

  • Standard Blister Packs: 6 x 10 Tablets

  • Standard Blister Packs: 10 x 10 Tablets

  • Custom Packaging: Bulk packaging or specific blister configurations are available as advised by the buyer to meet local regulatory needs.

Storage

To maintain product stability and integrity:

  • Store at controlled room temperature, typically below 25°C (77°F).

  • Excursions permitted between 15°C and 30°C (59°F and 86°F).

  • Store in the original package to protect from moisture and light.

Disclaimer: The information provided above is for general informational and B2B trade purposes only. It is not intended as medical advice. Tofacitinib is a prescription-only medicine and should be used strictly under the guidance of a qualified healthcare professional.